BioRestorative Therapies (BRTX) vs Genprex (GNPX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioRestorative Therapies is the larger company by market cap ($2.6 million vs $2.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRTX | GNPX |
|---|---|---|
| Share price | $1.89 | $2.75 |
| Market cap | $2.61M | $2.25M |
| 1-day change | -15.63% | +4.96% |
| EPS (TTM) | $-21.40 | $-9.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $34.40 | $1,210.00 |
| 52-week low | $1.75 | $2.53 |
| Distance from 52-week high | -94.51% | -99.77% |
| Analyst consensus | buy | — |
| Avg. price target upside | +15773.02% | — |
| Average volume | 26.05K | 247.06K |
| Shares outstanding | 1.38M | 819.71K |
| Employees | 13 | 13 |
| Sector | Health Care | Health Care |
| Industry | Managed Health Care | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BioRestorative Therapies
BRTX stock →BioRestorative Therapies, Inc. develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.
Health Care · Managed Health Care · 13 employees
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
BRTX vs GNPX FAQ
Which is bigger, BioRestorative Therapies or Genprex?
BioRestorative Therapies (BRTX) is larger, with a market capitalization of $2.61M compared with $2.25M for Genprex (GNPX).
Are BioRestorative Therapies and Genprex in the same industry?
Both are in the Health Care sector, but in different industries: Managed Health Care for BioRestorative Therapies and Biotechnology: Pharmaceutical Preparations for Genprex.